|
S.V. Guliaev, A.D. Meshkov, P.I. Novikov, A.G. Semenovikh, N.V. Nikiforova, N.R. Nosova
Efficacy of aggressive immunosuppressive therapy in patient with fulminant Shoenlein-Henoch purpura
|
№3 / 2011
|
|
S.P. Fomina, I.V. Bagdasarova, T. Pavlenko
Steroid-resistant nephritic syndrome in childhood: single-centre experience
|
№3 / 2011
|
|
Yu.S. Miluvanova, L.Yu. Milovanova, L.V. Kozlovskaya
Variants of renal osteodystrophy
|
№3 / 2011
|
|
V.Yu. Shilo, A.Yu. Denisov
Treatment of anemia in chronic kidney disease: the present, the past and the future
|
№3 / 2011
|
|
Autosomal-dominant polycystic kidney disease: perspectives of treatment
|
№3 / 2011
|
|
J.S. Milovanov, L.J. Milovanova, L.V. Kozlovskaya
Anaemia in chronic kidney disease: pathogenesis, prognostic sighnificance, treatment
|
№6 / 2010
|
|
I.A. Bondar, V.V. Klimontov
Intracellular signalling pathways in diabetic nephropathy: new targets for nephroprotection
|
№5 / 2010
|
|
L.V. Kozlovskaya
Focal segmental glomerulosclerosis: focus on cyclosporine
|
№5 / 2010
|
|
*
Nephrotic crise
|
№5 / 2010
|
|
*
Hantavirus-induced renal damage: a call for the nephrologist
|
№5 / 2010
|
|
*
Scleroderma renal crisis: are there any hopes for changes?
|
№5 / 2010
|
Русский
